TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 101 filers reported holding TANGO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131,131,044 | +280.9% | 11,645,741 | +12.3% | 0.01% | +266.7% |
| Q2 2023 | $34,424,403 | -54.2% | 10,368,796 | -45.5% | 0.00% | 0.0% |
| Q1 2023 | $75,120,538 | +14.1% | 19,017,858 | +109.4% | 0.00% | -57.1% |
| Q4 2022 | $65,856,673 | +158.5% | 9,083,679 | +29.1% | 0.01% | +133.3% |
| Q3 2022 | $25,479,000 | -26.3% | 7,038,340 | -7.8% | 0.00% | 0.0% |
| Q2 2022 | $34,572,000 | -33.7% | 7,631,917 | +11.0% | 0.00% | -25.0% |
| Q1 2022 | $52,120,000 | -33.7% | 6,875,975 | -4.3% | 0.00% | -33.3% |
| Q4 2021 | $78,574,000 | -2.8% | 7,182,188 | +14.9% | 0.01% | 0.0% |
| Q3 2021 | $80,838,000 | – | 6,251,913 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $87,719,000 | 57.68% |
| TCG Crossover Management, LLC | 1,172,250 | $5,310,000 | 2.26% |
| Boxer Capital, LLC | 6,871,642 | $31,129,000 | 1.97% |
| Cormorant Asset Management, LP | 4,507,843 | $20,421,000 | 1.54% |
| Casdin Capital, LLC | 3,500,000 | $15,855,000 | 1.34% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $8,706,000 | 1.02% |
| Samsara BioCapital, LLC | 630,000 | $2,854,000 | 0.76% |
| Southpoint Capital Advisors LP | 4,500,000 | $20,385,000 | 0.58% |
| HARVARD MANAGEMENT CO INC | 708,385 | $3,209,000 | 0.37% |
| EcoR1 Capital, LLC | 2,302,065 | $10,428,000 | 0.36% |